Navigation Links
Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
Date:6/13/2012

WEST BRIDGEWATER, Mass., June 13, 2012 /PRNewswire/ -- Cardiosolutions Inc., an emerging leader in structural heart solutions for valvular heart disease, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its  Dexterity™ Steerable Introducer, a next generation structural heart access introducer and delivery conduit. The Dexterity™ Steerable Introducer is designed to provide physicians straightforward and uncomplicated access to the heart anatomy by simplifying the cardiac trans-septal procedure and facilitating passage of therapies into the entire left atrium, left ventricle and associated heart structures. The Dexterity™ Steerable Introducer is intended to be used for the advancement and delivery of various cardiovascular catheters into the heart, including the left side of the cardiac anatomy through the inter-atrial septum.

Dr. Thomas Piemonte, Chief Medical Officer for Cardiosolutions and Director, Interventional Cardiovascular Medicine and Cardiac Catheterization Laboratory at the Lahey Clinic in Burlington Massachusetts stated, "The Dexterity™ Steerable Introducer is an exciting, versatile product that permits unparalleled access to the heart chambers. We believe it is an ideal and essential tool for the Interventional or Electrophysiology physician who needs precise catheter placement with combined ease of use." Steven Tallarida, President and CEO of Cardiosolutions further offered, "The ability to generate revenue from our Dexterity™ Steerable Introducer, while simultaneously advancing the development of our Mitra-Spacer™ technology shows our ability to create value early in the startup cycle.  We now have a specialty introducer product that complements the development of the Mitra-Spacer™, a potential blockbuster device that is intended to mitigate mitral regurgitation."

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as standard procedure for a number of complicated interventional procedures. Evolving interventional techniques allow treatment of rhythm disorders, paravalvular leaks, ventricular septal defects and valve replacement. Until recently, therapy for these diseases was limited to patients in whom severe comorbidities lead to contraindications to surgery. Cardiosolutions Dexterity™ Steerable Introducer simplifies many of these procedures and could provide lower cost, less invasive procedures leading to superior patient results.

About Cardiosolutions, Inc.
Cardiosolutions, Inc. ("Cardiosolutions" or the "Company") www.cardiosolutionsinc.com  is developing a less invasive, percutaneous alternative to open heart surgical repair of the mitral valve. The Dexterity™ Steerable Introducer System and Mitra-Spacer™ could provide a long-term therapeutic substitute to this complicated open heart valve repair procedure. In this connection, it would address the unmet clinical need for a minimally invasive solution to the nearly 200,000 patients diagnosed annually with moderate to severe mitral regurgitation who currently forgo treatment because they cannot tolerate a highly invasive procedure. The Company is another novel medical device technology incubated within and spun out of STD Med, Inc. (Stoughton MA.) partnering with BioVentures Investors, a leading Medtech venture firm.  


'/>"/>
SOURCE Cardiosolutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cochlear Americas Receives FDA Approval of the Worlds Thinnest, Full Length Electrode for Cochlear Implantation
2. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
3. PharmaNet/i3 Receives Distinguished Partner Award from the US Chinese Anti-Cancer Association
4. ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
5. Breathe Technologies Non-Invasive Open Ventilation (NIOV™) System Receives Medical Design Award
6. The Largest Private Funder Of Melanoma Research Receives Vital Support From Activist Jeffrey Epstein
7. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
8. Minacs Receives New URAC Pharmacy Benefit Management Accreditations
9. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
10. Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
11. InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... ORANGEBURG, N.Y. , Sept. 6, 2017   PDI ... today announced it will host an educational session focused ... line-associated bloodstream infection (CLABSI) prevention at the 2017 Annual ... meeting, which will take place at the ... Arizona from Sept. 16-19, will also feature ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... ... a board-certified veterinary oncologist, has agreed to serve as strategic adviser to ... Dr. Tripp is founder of the Bridge Animal Referral Center (BARC) in ...
(Date:9/19/2017)... TX (PRWEB) , ... September 19, 2017 , ... ... the United States, named Dr. Howard Ng, as the new Medical Director of its ... be the new facility Medical Director of our Pflugerville- FM 685 location,” said Dr. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Ron Norman, CEO ... today the importance of making a distinct rather than generic impression in the job ... to look through a stack of resumes knows that the first impression they give ...
(Date:9/19/2017)... ... September 19, 2017 , ... When it comes to household safety, there are ... on how to keep babies and toddlers safe, and there's no better time for ... Great Time to Check Labels, Brands that sell all kinds of common consumer products ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... app offering. The new app provides a modern design with a more streamlined ... experience. , The fred’s Pharmacy mobile app includes hundreds of digital coupons that ...
Breaking Medicine News(10 mins):